Labs in Court - G2 Intelligence

Recent Decision in FCA Case Has Key Implications for Labs

The decision deepens a split among circuit courts regarding how to determine liability for false claims

Start a Free Trial for immediate access to this article

Already a member? Log in here

Cases filed or resolved by the U.S. Department of Justice in the fourth quarter reveal the same compliance issues from early in 2024

Start a Free Trial for immediate access to this article

Already a member? Log in here

Recent False Claims Act settlements underscore the government’s emphasis on individual accountability in healthcare fraud matters

Start a Free Trial for immediate access to this article

Already a member? Log in here

Recent enforcement actions involved usual targets such as COVID-19, genetic, and urine drug testing, but EKRA also made an appearance

Start a Free Trial for immediate access to this article

Already a member? Log in here

Recent DOJ settlements continue to focus on issues involving medical necessity and marketer compensation

Start a Free Trial for immediate access to this article

Already a member? Log in here